Bildkälla: Stockfoto

Nexstim: A Change of Focus - Redeye

Redeye is cautiously optimistic to yesterday’s licensing agreement between Nexstim and Magnus Medical and gives an initial take.

Redeye is cautiously optimistic to yesterday’s licensing agreement between Nexstim and Magnus Medical and gives an initial take.
Börsvärldens nyhetsbrev
ANNONSER